about
Cancer Prevention: Lessons Learned and Future Directions.Targeting regulatory T cells in tumors.Harnessing antitumor immunity: Employment of tumor recall antigens to optimize the inflammatory response to cancerColorectal cancer prevention: Immune modulation taking the stage.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets.Cancer immunoprevention: from mice to early clinical trials.
P2860
Q38652183-E5CB3237-EA52-4C6C-A4E5-93342FEDA181Q38703565-0ED4D824-3AFC-4D57-AC65-5E194894DF86Q39270453-62460021-1504-42A3-8DA7-5A2F2271FC7EQ49391998-BA76F2A6-024D-458E-8AF5-65EB7836963CQ50191433-A23084B5-42CC-4D73-B47F-A8A07FFCEA50Q52560420-F38A7A16-5D2D-4B0C-A1E4-CDE9926A460CQ55472478-69378EC9-6E08-4552-80A5-D1C079000478
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Emerging strategies for cancer immunoprevention.
@en
type
label
Emerging strategies for cancer immunoprevention.
@en
prefLabel
Emerging strategies for cancer immunoprevention.
@en
P2093
P2860
P356
P1433
P1476
Emerging strategies for cancer immunoprevention.
@en
P2093
F McAllister
J C Roeser
P2860
P2888
P304
P356
10.1038/ONC.2015.98
P407
P577
2015-09-14T00:00:00Z
P6179
1023777364